Zhejiang Medicine Co., Ltd. (SHA: 600216)
China flag China · Delayed Price · Currency is CNY
16.75
+0.11 (0.66%)
Nov 19, 2024, 3:00 PM CST

Zhejiang Medicine Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
8,9987,7628,0739,0887,2947,023
Upgrade
Other Revenue
32.1132.1143.2341.332.5320.59
Upgrade
Revenue
9,0307,7948,1169,1297,3277,044
Upgrade
Revenue Growth (YoY)
14.77%-3.96%-11.10%24.60%4.02%2.70%
Upgrade
Cost of Revenue
5,7535,3925,4385,5304,4104,271
Upgrade
Gross Profit
3,2782,4022,6783,5992,9172,772
Upgrade
Selling, General & Admin
1,6451,4811,3121,5461,5371,971
Upgrade
Research & Development
799.87860.07809.28806.86546.09450.42
Upgrade
Other Operating Expenses
86.5278.4369.8675.1773.0469.95
Upgrade
Operating Expenses
2,5492,4202,1882,4392,1402,504
Upgrade
Operating Income
729.03-18.15489.741,160777.42268.47
Upgrade
Interest Expense
-28.51-28.34-33.11-39.54-46.27-25.71
Upgrade
Interest & Investment Income
19.3616.5113.1857.42139.5645.05
Upgrade
Currency Exchange Gain (Loss)
36.5936.5966.6-64.31-38.4619.93
Upgrade
Other Non Operating Income (Expenses)
-7.0721.09-36.73-2.69-31.87-9.39
Upgrade
EBT Excluding Unusual Items
749.427.7499.671,111800.38298.35
Upgrade
Impairment of Goodwill
-9.23-9.23-8.12---5.06
Upgrade
Gain (Loss) on Sale of Investments
-43.07-28.59-56.5151.7330.4866.9
Upgrade
Gain (Loss) on Sale of Assets
315.77323.57-1.37-7.95-23.48-2.07
Upgrade
Asset Writedown
-36.99---46.19-9.85-4.92
Upgrade
Other Unusual Items
49.8249.8257.7144.7653.4544.29
Upgrade
Pretax Income
1,026363.28491.391,154850.98397.5
Upgrade
Income Tax Expense
171.2186.48128.77268.97191.34105.54
Upgrade
Earnings From Continuing Operations
854.49276.79362.61884.56659.64291.95
Upgrade
Minority Interest in Earnings
123.47152.85176.96160.7657.7650.82
Upgrade
Net Income
977.95429.64539.571,045717.4342.77
Upgrade
Net Income to Common
977.95429.64539.571,045717.4342.77
Upgrade
Net Income Growth
174.36%-20.37%-48.38%45.71%109.29%-5.97%
Upgrade
Shares Outstanding (Basic)
956961964959957952
Upgrade
Shares Outstanding (Diluted)
956961964959957952
Upgrade
Shares Change (YoY)
-2.50%-0.31%0.47%0.26%0.46%-0.75%
Upgrade
EPS (Basic)
1.020.450.561.090.750.36
Upgrade
EPS (Diluted)
1.020.450.561.090.750.36
Upgrade
EPS Growth
181.39%-20.13%-48.62%45.33%108.33%-5.26%
Upgrade
Free Cash Flow
282.96-162.56-455.39197.05721.37-126.38
Upgrade
Free Cash Flow Per Share
0.30-0.17-0.470.210.75-0.13
Upgrade
Dividend Per Share
0.1500.1500.1700.3300.2301.000
Upgrade
Dividend Growth
-11.76%-11.76%-48.48%43.48%-77.00%566.67%
Upgrade
Gross Margin
36.30%30.82%33.00%39.43%39.81%39.36%
Upgrade
Operating Margin
8.07%-0.23%6.03%12.71%10.61%3.81%
Upgrade
Profit Margin
10.83%5.51%6.65%11.45%9.79%4.87%
Upgrade
Free Cash Flow Margin
3.13%-2.09%-5.61%2.16%9.85%-1.79%
Upgrade
EBITDA
1,371640.441,1711,7471,281756.2
Upgrade
EBITDA Margin
15.18%8.22%14.42%19.14%17.49%10.74%
Upgrade
D&A For EBITDA
641.92658.59680.81586.79503.81487.74
Upgrade
EBIT
729.03-18.15489.741,160777.42268.47
Upgrade
EBIT Margin
8.07%-0.23%6.03%12.71%10.61%3.81%
Upgrade
Effective Tax Rate
16.69%23.81%26.21%23.32%22.48%26.55%
Upgrade
Revenue as Reported
9,0307,7948,1169,1297,3277,044
Upgrade
Advertising Expenses
-21.2519.5921.320.829.58
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.